EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells

Sini M Kinnunen iD, Katja Eloranta, Marjut Pihlajoki iD, Mika J Välimäki, Saana Pohjavaara, Emilie Indersie iD, Stefano Cairo, Aarni Kuusinen, Heikki Ruskoaho, Markku Heikinheimo

PLOS One · 2026

DOI: 10.1371/journal.pone.0342565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Sini M Kinnunen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Program and Division of Pharmacology and Pharmacotherapy, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Hepatoblastoma, GATA4 Transcription Factor, Apoptosis, Liver Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jane and Aatos Erkko Foundation, Sigrid Jusélius Foundation, sinki University Hospital Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatoblastoma is the most common pediatric liver tumor, and it primarily affects young children. Despite improved treatment results due to modern chemotherapy and advanced surgical techniques, there is urgent need to improve the long-term prognosis of hepatoblastoma patients. Elevated expression of transcription factor GATA4 has been associated with pro-tumorigenic functions in hepatoblastoma. Herein, we explored the effects of a novel series of GATA4-targeted compounds (3i-2010–3i-2014) in several hepatoblastoma cell models. To this end, we assessed cell viability (2D and 3D), caspase 3/7 activity, cell cycle process with automated fluorescence microscopy, and RNA and protein expression using quantitative PCR, RNA-sequencing, and western blotting after treating cells with GATA4-targeted compounds. The GATA4-targeted compounds reduced hepatoblastoma cell viability but affected also healthy control cells when high doses were applied. Out of the five compounds used, the 3i-2012 was the most potent. This compound induced G0/G1 phase cell cycle arrest, increased caspase activity, and resulted in changes in transcriptome of hepatoblastoma cells. The differentially expressed genes (DEGs) were associated with cell cycle regulation. Transcription factor target analysis demonstrated that a notable proportion of DEGs were likely regulated by GATA4. In conclusion, 3i-2012 decreases hepatoblastoma cell survival by disturbing cell cycle regulation in the tumor cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaGATA4 Transcription FactorApoptosisLiver NeoplasmsAntineoplastic AgentsHumansCell SurvivalCell Line, TumorGene Expression Regulation, NeoplasticCaspase 3Caspase 7Cell Cycle

Substanzen

GATA4 Transcription FactorGATA4 protein, humanCaspase 3Caspase 7Antineoplastic Agents

Autor:innen und Institutionen

  • Drug Research Program and Division of Pharmacology and Pharmacotherapy, University of Helsinki, Helsinki, Finland.
  • Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Cancer Cell Circuitry Laboratory, Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Xentech, Evry, France.
  • Champions Oncology, Hackensack, New Jersey, United States of America.

ORCID-Profile: Sini M Kinnunen, Marjut Pihlajoki, Emilie Indersie

Förderung

  • Jane and Aatos Erkko Foundation
  • Sigrid Jusélius Foundation
  • sinki University Hospital Research Funds
  • Academy of Finland
  • Finnish Foundation for Cardiovascular Research

Zitieren

APA

Kinnunen, S. M., Eloranta, K., Pihlajoki, M., Välimäki, M. J., Pohjavaara, S., Indersie, E., Cairo, S., Kuusinen, A., Ruskoaho, H., & Heikinheimo, M. (2026). GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells. PLOS One. https://doi.org/10.1371/journal.pone.0342565

Vancouver

Kinnunen SM, Eloranta K, Pihlajoki M, Välimäki MJ, Pohjavaara S, Indersie E, et al. GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells. PLOS One. 2026. doi:10.1371/journal.pone.0342565

BibTeX
@article{Kinnunen2026,
  author = {Kinnunen, Sini M and Eloranta, Katja and Pihlajoki, Marjut and Välimäki, Mika J and Pohjavaara, Saana and Indersie, Emilie and Cairo, Stefano and Kuusinen, Aarni and Ruskoaho, Heikki and Heikinheimo, Markku},
  title = {GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0342565}
}
Kostenlos starten →